Drugs / UR-63325
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01260753 | Dec 2010 → Mar 2011 | seasonal allergic rhinitis | Palau Pharma S.L.U. | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | UR-63325 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01260753 ↗ |
| Known as | Seliforant | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314396 ↗ |
| Action | Inhibit | “Histamine H4 receptor antagonist” CHEMBL5314396 ↗ |
| Modality | Small molecule | — CHEMBL5314396 ↗ |
| Target | HRH4 | “Histamine H4 receptor antagonist” CHEMBL5314396 ↗ |